United Kingdom · Question · Written question
UIN 20108
Alzheimer's Disease: Drugs
Original
Introduced
13 December 2024
Last action
19 December 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 December 2024
Summary
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the adequacy of NICE methodology in appraising innovative medicines for licensed for Alzheimer's Disease.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 December 2024
Written question
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the adequacy of NICE methodology in appraising innovative medicines for licensed for Alzheimer's Disease.
Source: Commons
19 December 2024
Answer
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes it uses to develop recommendations on whether new medicines represent a clinically and cost-effective use of National Health Service resources. The N...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-12-13/20108
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1749902
- uk · wq-1749902 · source updated 19 December 2024